MedPath
FDA Approval

Anticoagulant Sodium Citrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
CSL Plasma Inc.
DUNS: 942344649
Effective Date
January 10, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Gadofosveset trisodium(40 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

CSL Plasma Inc.

CSL Plasma Inc.

942344649

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Sodium Citrate

Product Details

NDC Product Code
81839-782
Application Number
BA125750
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
May 5, 2022
WaterInactive
Code: 059QF0KO0RClass: IACT
Citric Acid monohydrateInactive
Code: 2968PHW8QPClass: IACT
Code: B22547B95KClass: ACTIMQuantity: 40 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath